Oppenheimer & Co’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.61M | Buy |
89,062
+7,300
| +9% | +$749K | 0.1% | 208 |
|
|
2025
Q4 | $8.68M | Sell |
81,762
-9,735
| -11% | -$1.13M | 0.12% | 182 |
|
|
2025
Q3 | $11.6M | Sell |
91,497
-6,917
| -7% | -$823K | 0.14% | 157 |
|
|
2025
Q2 | $12.1M | Sell |
98,414
-2,225
| -2% | -$254K | 0.16% | 141 |
|
|
2025
Q1 | $10.2M | Sell |
100,639
-131
| -0.1% | -$12.8K | 0.15% | 143 |
|
|
2024
Q4 | $9.31M | Sell |
100,770
-4,241
| -4% | -$416K | 0.14% | 150 |
|
|
2024
Q3 | $10.1M | Sell |
105,011
-12,240
| -10% | -$1.1M | 0.15% | 145 |
|
|
2024
Q2 | $10.1M | Sell |
117,251
-950
| -0.8% | -$79.7K | 0.16% | 130 |
|
|
2024
Q1 | $9.76M | Buy |
118,201
+6,280
| +6% | +$460K | 0.16% | 138 |
|
|
2023
Q4 | $7.47M | Sell |
111,921
-1,580
| -1% | -$102K | 0.14% | 178 |
|
|
2023
Q3 | $7.62M | Buy |
113,501
+10,958
| +11% | +$754K | 0.16% | 148 |
|
|
2023
Q2 | $6.94M | Sell |
102,543
-21,890
| -18% | -$1.37M | 0.14% | 168 |
|
|
2023
Q1 | $6.73M | Sell |
124,433
-11,072
| -8% | -$644K | 0.14% | 168 |
|
|
2022
Q4 | $8.1M | Sell |
135,505
-5,275
| -4% | -$287K | 0.18% | 128 |
|
|
2022
Q3 | $6.37M | Sell |
140,780
-36,114
| -20% | -$1.81M | 0.15% | 159 |
|
|
2022
Q2 | $7.89M | Sell |
176,894
-8,045
| -4% | -$413K | 0.17% | 132 |
|
|
2022
Q1 | $10.5M | Sell |
184,939
-9,785
| -5% | -$511K | 0.19% | 113 |
|
|
2021
Q4 | $10.1M | Sell |
194,724
-1,124
| -0.6% | -$58K | 0.18% | 117 |
|
|
2021
Q3 | $11.7M | Buy |
195,848
+31
| +0% | +$1.95K | 0.22% | 95 |
|
|
2021
Q2 | $12.2M | Buy |
195,817
+2,791
| +1% | +$186K | 0.22% | 100 |
|
|
2021
Q1 | $12.6M | Sell |
193,026
-59,806
| -24% | -$3.9M | 0.25% | 83 |
|
|
2020
Q4 | $16.6M | Buy |
252,832
+2,451
| +1% | +$144K | 0.35% | 60 |
|
|
2020
Q3 | $12.9M | Sell |
250,381
-20,929
| -8% | -$1.07M | 0.32% | 63 |
|
|
2020
Q2 | $13.4M | Sell |
271,310
-4,980
| -2% | -$269K | 0.35% | 60 |
|
|
2020
Q1 | $14.1M | Sell |
276,290
-4,761
| -2% | -$275K | 0.43% | 50 |
|
|
2019
Q4 | $15.5M | Sell |
281,051
-7,165
| -2% | -$389K | 0.38% | 56 |
|
|
2019
Q3 | $14.5M | Sell |
288,216
-3,545
| -1% | -$178K | 0.4% | 53 |
|
|
2019
Q2 | $14.7M | Buy |
291,761
+1,402
| +0.5% | +$68K | 0.4% | 53 |
|
|
2019
Q1 | $13.5M | Sell |
290,359
-202
| -0.1% | -$10.2K | 0.36% | 60 |
|
|
2018
Q4 | $14.3M | Buy |
290,561
+3,771
| +1% | +$214K | 0.45% | 48 |
|
|
2018
Q3 | $17.8M | Sell |
286,790
-6,285
| -2% | -$382K | 0.45% | 46 |
|
|
2018
Q2 | $15.8M | Sell |
293,075
-33,380
| -10% | -$1.67M | 0.43% | 48 |
|
|
2018
Q1 | $14.8M | Sell |
326,455
-4,526
| -1% | -$194K | 0.38% | 56 |
|
|
2017
Q4 | $13M | Buy |
330,981
+1,789
| +0.5% | +$68K | 0.33% | 63 |
|
|
2017
Q3 | $12.1M | Buy |
329,192
+10,936
| +3% | +$390K | 0.32% | 65 |
|
|
2017
Q2 | $12.3M | Sell |
318,256
-87,541
| -22% | -$3.21M | 0.34% | 62 |
|
|
2017
Q1 | $13.8M | Sell |
405,797
-23,016
| -5% | -$756K | 0.39% | 54 |
|
|
2016
Q4 | $14.1M | Sell |
428,813
-18,930
| -4% | -$614K | 0.41% | 53 |
|
|
2016
Q3 | $14.5M | Sell |
447,743
-755
| -0.2% | -$24.5K | 0.42% | 57 |
|
|
2016
Q2 | $13.9M | Sell |
448,498
-11,017
| -2% | -$345K | 0.41% | 53 |
|
|
2016
Q1 | $13.8M | Sell |
459,515
-2,322
| -0.5% | -$64.1K | 0.42% | 53 |
|
|
2015
Q4 | $12.8M | Buy |
461,837
+2,414
| +0.5% | +$68.7K | 0.38% | 57 |
|
|
2015
Q3 | $14M | Buy |
459,423
+84,931
| +23% | +$2.96M | 0.43% | 44 |
|
|
2015
Q2 | $13.7M | Sell |
374,492
-33,579
| -8% | -$1.2M | 0.38% | 54 |
|
|
2015
Q1 | $14.4M | Sell |
408,071
-29,202
| -7% | -$999K | 0.39% | 54 |
|
|
2014
Q4 | $13.4M | Buy |
437,273
+43,281
| +11% | +$1.35M | 0.38% | 50 |
|
|
2014
Q3 | $11.6M | Sell |
393,992
-62,912
| -14% | -$1.92M | 0.34% | 55 |
|
|
2014
Q2 | $13M | Sell |
456,904
-32,054
| -7% | -$894K | 0.39% | 47 |
|
|
2014
Q1 | $14M | Sell |
488,958
-2,011
| -0.4% | -$52.3K | 0.42% | 43 |
|
|
2013
Q4 | $13M | Buy |
490,969
+1,885
| +0.4% | +$52.4K | 0.42% | 44 |
|
|
2013
Q3 | $13.4M | Buy |
489,084
+13,589
| +3% | +$349K | 0.47% | 38 |
|
|
2013
Q2 | $10.9M | Buy |
+475,495
| New | +$10.7M | 0.42% | 42 |
|
Other funds holding EHC
VPM
VCM
Oppenheimer & Co's EHC Position: Q1 2026 in Review
Oppenheimer & Co increased its Encompass Health (EHC) stake by 8.9% in Q1 2026, buying an estimated $749K and bringing the position to 89,062 shares worth $8.61M. The position accounts for 0.1% of the portfolio, ranked #208.
Oppenheimer & Co first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.8M in Q3 2018. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Oppenheimer & Co held 89,062 shares of Encompass Health worth $8.61M as of Q1 2026.
- Oppenheimer & Co bought 7,300 Encompass Health shares in Q1 2026, an estimated $749K.
- Encompass Health made up 0.1% of Oppenheimer & Co's portfolio in Q1 2026, its #208 holding.
- Oppenheimer & Co first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's Encompass Health position peaked at $17.8M in Q3 2018.
- 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.